| Revenue growth | Value |
|---|---|
| 3Y CAGR | +16% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +5% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,758.00 +165.40 (6.38%) | 19,728.46 | 29.1 | 5.85 | ||
PfizerPFIZER | ₹3,995.80 -19.00 (0.47%) | 18,372.52 | 24.99 | 4.37 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,727.00 +58.00 (0.87%) | 16,686.38 | 98.37 | 19.12 | ||
Jubilant PharmovaJUBLPHARMA | ₹1,073.30 +61.20 (6.05%) | 16,121.96 | 45.88 | 2.27 |